🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/RT-2026-155Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Retatrutide 20 mg

RT-2026-155Lot RT20-2611001-1Analyzed November 20, 2026
Retatrutide 20 mg vial as received

Timeline

Ordered
November 18, 2026
Received
November 20, 2026
Analyzed
November 20, 2026

Sample

Name
Retatrutide 20 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder

Testing

Client
P-LabTest
Test type
Content & purity, fentanyl
Method
HPLC-UV

Group test

Vials tested
1 vial, shared result
Contributors
7 people
Shared by
Joe Glez, Raul Flores, Carlos Delgado, Laura Reveles, Joe Glez 2 (Saudi Vel Spot), Raul Flores (yari), Joe Glez 3
Content, how much is in it
19.00mg
Label claim: 20 mg
Purity, how clean it is
99.5%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Fentanyl
NOT DETECTED
Screening cutoff 20 ng/mL

Chromatogram

HPLC-UV

mAU-10001002003004000481216202428Retention time (min)13.40
13.40 min, Retatrutide, 99.5%

Analyst Comments

White lyophilized powder, blue flip-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026

Verification Code

RT-7TA7-VIFO
Verify at purilab.org/verify/RT-7TA7-VIFO

Scan to Verify

RT-7TA7-VIFO

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1